National Women's Annual Clinical Report 2010

More documents

Recommendations

Info

9.4.9 Positive pressure ventilation and CPAP use in NW and across Australia and New Zealand at 24-27 weeks gestation (ANZNN benchmarking) These data compare the use of IPPV and CPAP in NW and across the Australia and New Zealand Neonatal Network. The Network collects standardised data from all NICU in Australia and New Zealand. The median data presented here are for all babies ventilated (ie babies not ventilated are excluded). 100% 95% 90% 85% 80% 75% ANZNN NW 70% 1995 1998 2001 2004 2007 2010 Figure 100: Percentage on IPPV (24-27 wks ANZNN assigned) 30 25 20 15 10 5 ANZNN NW 0 1995 1998 2001 2004 2007 2010 Figure 102: Median days on IPPV (24-27 wks ANZNN assigned) 100% 95% 90% 85% 80% 75% 70% 65% ANZNN NW 60% 1995 1998 2001 2004 2007 2010 Figure 101: Percentage on CPAP (24-27 wks ANZNN assigned) 50 40 30 20 10 ANZNN NW 0 1995 1998 2001 2004 2007 2010 Figure 103: Median days on CPAP (24-27 wks ANZNN assigned) Since ACH changed its policy on ventilatory support in 1997 the use of CPAP has been high and IPPV use and duration has tended to be lower relative to ANZNN. Current ACH data are consistent with previous years but contemporary ANZNN data are not as yet available for comparison. 138
9.4.10 Positive pressure ventilation and CPAP use in NW and across Australia and New Zealand at 28-31 weeks gestation (ANZNN benchmarking) 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% ANZNN NW 1995 1998 2001 2004 2007 2010 Figure 104: Percentage on IPPV (28-31 wks ANZNN assigned) 10 9 8 7 6 5 4 3 2 1 0 ANZNN NW 1995 1998 2001 2004 2007 2010 Figure 105: Median days on IPPV (28-31 wks ANZNN assigned) 100% 90% 80% 70% 60% 50% ANZNN NW 40% 1995 1998 2001 2004 2007 2010 Figure 106: Percentage on CPAP (28-31 wks ANZNN assigned) 15 10 5 ANZNN NW 0 1995 1998 2001 2004 2007 2010 Figure 107: Median days on CPAP (28-31 wks ANZNN assigned) The pattern of respiratory support in NW babies of 28-31 weeks gestation parallels that seen in the less mature babies. Again recent ANZNN data are not currently available for comparison. 139
Page 1 and 2:
National Women’s Annual Clinical
Page 3 and 4:
It is my pleasure to present the 20
Page 5 and 6:
7 LABOUR AND BIRTH OUTCOMES .......
Page 7 and 8:
Table 50: Neonatal outcomes followi
Page 9 and 10:
Table 153: Preterm birth and matern
Page 11 and 12:
Table 258: Perinatal mortality rate
Page 13 and 14:
Figure 53: Mode of birth (1991-2010
Page 15:
Chapter 1 INTRODUCTION 1
Page 18 and 19:
Chapter 8: Postnatal care This chap
Page 20 and 21:
1.5.3 Gynaecologic data quality As
Page 23 and 24:
2 SERVICE PROVISION 2.1 Maternity s
Page 25 and 26:
2.2.4 Antenatal and Postnatal Wards
Page 27 and 28:
The service has access to the ACH L
Page 29 and 30:
2.5.3 University Links There are cl
Page 31 and 32:
Reportable events All incidents (mi
Page 33:
Chaptern 3 SUMMARY STATISTICS 19
Page 36 and 37:
3.2 Summary of maternal outcomes 20
Page 38 and 39:
Rate Table 7: Perinatal related mor
Page 40 and 41:
Maternal indicator Caesarean sectio
Page 42 and 43:
50 45 40 35 30 25 20 15 10 5 0 % Ep
Page 45 and 46:
4 MATERNAL DEMOGRAPHY This chapter
Page 47 and 48:
4.2.2 Maternal ethnicity When more
Page 49 and 50:
% 60 50 40 30 20 10 0 NZ European M
Page 51 and 52:
4.5 Body mass index Thirty five per
Page 53 and 54:
% 100 80 60 40 20 0 European Maori
Page 55:
Women booked with a private obstetr
Page 59 and 60:
5 ANTENATAL COMPLICATIONS This chap
Page 61 and 62:
Ethnic differences in rates of pret
Page 63 and 64:
of women under 20 with SGA babies s
Page 65 and 66:
Perinatal deaths in term SGA infant
Page 67 and 68:
The rate of multiple pregnancy rema
Page 69 and 70:
Summary / Implications Multiple pre
Page 71 and 72:
5.4.1 Demographic characteristics o
Page 73 and 74:
5.4.5 Perinatal losses Diabetes Per
Page 75 and 76:
A confirmed placental abruption is
Page 77 and 78:
70 60 50 40 30 20 10 0 % Gestationa
Page 79 and 80:
5.7 Body Mass Index Methods BMI is
Page 81 and 82:
% European Maori Pacific Other Asia
Page 83 and 84:
50 45 40 35 30 25 20 15 10 5 0 % Eu
Page 85 and 86:
16 % 40 14 12 10 8 6 4 2 0 Iatrogen
Page 87:
Table 38: Mothers with babies diagn
Page 91 and 92:
6 LABOUR AND BIRTH This chapter inc
Page 93 and 94:
Table 39: Maternal demographic char
Page 95 and 96:
Table 40: Gestation at birth among
Page 97 and 98:
Women given syntocinon prior to 3 c
Page 99 and 100:
70 60 50 40 30 20 10 0 % NZ Europea
Page 101 and 102: 6.5 Caesarean section WHA Maternity
Page 103 and 104: Caesarean section rate 60 50 40 30
Page 105 and 106: Sixty percent of para 1 women with
Page 107 and 108: 6.6 Instrumental vaginal birth WHA
Page 109 and 110: Table 52: Neonatal outcomes followi
Page 111 and 112: 6.10 Obstetric analgesia WHA Matern
Page 113 and 114: Table 56: GA use and mode of birth
Page 115 and 116: Table 58: Interventions and outcome
Page 117 and 118: Chaptern 7 LABOUR and BIRTH OUTCOME
Page 119 and 120: 7 LABOUR and BIRTH OUTCOMES This ch
Page 121 and 122: 7.2 Third stage management Methods:
Page 123 and 124: Table 61: Postpartum haemorrhage ra
Page 125 and 126: 7.4 Emergency peripartum hysterecto
Page 127 and 128: Chaptern 8 POSTNATAL CARE 113
Page 129 and 130: 8 POSTNATAL CARE This chapter provi
Page 131 and 132: % 90 85 80 75 70 65 60 55 50 45 40
Page 133 and 134: 8.2 Postnatal admissions Methods Pr
Page 135 and 136: Table 70: Reason for admission to N
Page 137 and 138: Chaptern 9 NEWBORN SERVICES 123
Page 139 and 140: 9 NEWBORN SERVICES This chapter pro
Page 141 and 142: 9.2 NICU occupancy For 2010 the ver
Page 143 and 144: Number 700 600 500 400 300 200 100
Page 145 and 146: 9.3.4 Reasons for admission to NICU
Page 147 and 148: 9.4.3 Intraventricular haemorrhage
Page 149 and 150: 246 for 2010. This number is higher
Page 151: 9.4.8 Trends in the use of assisted
Page 155 and 156: 9.4.12 Term/post-term infants on as
Page 157 and 158: 9.5.2 Survival of inborn babies (23
Page 159 and 160: 20% 18% 16% 14% 12% 10% 8% 6% 4% AN
Page 161 and 162: 9.5.10 Postnatal corticosteroids (A
Page 163 and 164: express milk for many weeks before
Page 165 and 166: 9.9 Child Development Unit 9.9.1 Fo
Page 167 and 168: 9.9.2 Development at 4 years of chi
Page 169 and 170: Chapter 10 PERINATAL MORTALITY 155
Page 171 and 172: 10 PERINATAL MORTALITY This chapter
Page 173 and 174: Table 87: Perinatal related loss an
Page 175 and 176: 10.5 Causes of perinatal-related de
Page 177 and 178: Chapter 11 SEVERE MATERNAL MORBIDIT
Page 179 and 180: 11 SEVERE MATERNAL MORBIDITY This c
Page 181 and 182: Chapter 12 GYNAECOLOGY 167
Page 183 and 184: 12 GYNAECOLOGY This chapter provide
Page 185 and 186: 12.2 Termination of pregnancy Epsom
Page 187 and 188: 12.3 Second trimester Termination o
Page 189 and 190: 12.4 Gynaecology inpatient surgery
Page 191 and 192: Table 101: Demographic details of w
Page 193 and 194: ACHS Gynaecology Indicators: Injury
Page 195 and 196: 12.5 Gynaecologic laparoscopic proc
Page 197 and 198: 12.6 Hysterectomy Methods See Gynae
Page 199 and 200: % 80 70 60 50 40 30 20 10 0 Abdomin
Page 201 and 202: 12.7 Urogynaecology Methods As in p
Page 203 and 204:
Table 113: Complications of surgery
Page 205 and 206:
12.8 Colposcopy Methods: The data p
Page 207 and 208:
Referral smear cytology Table 117:
Page 209 and 210:
The number of treatments and percen
Page 211 and 212:
Number of patients 4.5 4 3.5 3 2.5
Page 213 and 214:
12.9 Gynaecologic oncology surgical
Page 215 and 216:
11.9.2 Gynaecologic oncology surger
Page 217 and 218:
203
Page 219 and 220:
Antenatal Summary screen; Reason fo
Page 221 and 222:
Postnatal Mothers Destination to Wa
Page 223 and 224:
APPENDIX 2. SUMMARY STATISTICS Tabl
Page 225 and 226:
Table 135: Time trends in nullipari
Page 227 and 228:
Table 141: Rates of smoking at book
Page 229 and 230:
Table 149: LMC at birth and materna
Page 231 and 232:
APPENDIX 4. ANTENATAL COMPLICATIONS
Page 233 and 234:
Table 157: Demographic characterist
Page 235 and 236:
4.4 Hypertensive disease Table 160:
Page 237 and 238:
Table 164: LMC at birth and BMI (20
Page 239 and 240:
APPENDIX 5. LABOUR AND BIRTH 5.1 In
Page 241 and 242:
5.2 Outcomes following induction Ta
Page 243 and 244:
Table 180: Mode of birth by LMC at
Page 245 and 246:
5.5 Operative births Table 189: Pri
Page 247 and 248:
Table 196: Referral for ECV (women
Page 249 and 250:
APPENDIX 6. LABOUR and BIRTH OUTCOM
Page 251 and 252:
APPENDIX 7. POSTNATAL CARE 7.1 Infa
Page 253 and 254:
Table 213: Maternal destination fol
Page 255 and 256:
Table 220: Admissions of inborn bab
Page 257 and 258:
Table 224: Admissions of outborn ba
Page 259 and 260:
8.2.5 Antenatal corticosteroids Tab
Page 261 and 262:
8.3.2 Intraventricular haemorrhage
Page 263 and 264:
8.4.1 Survival Table 240: Numbers o
Page 265 and 266:
8.5.4 Patent Ductus Arteriosus Tabl
Page 267 and 268:
Table 252: Inborn babies receiving
Page 269 and 270:
APPENDIX 9. PERINATAL MORTALITY Tab
Page 271 and 272:
Table 260: Cause of perinatal-relat
Page 273 and 274:
10.2 Gynaecology Inpatient Surgery
Page 275 and 276:
APPENDIX 11. GLOSSARY OF ABBREVIATI
Page 277 and 278:
APPENDIX 12. DEFINITIONS Antepartum
Page 279 and 280:
Lead Maternity Carer (LMC) The Lead
Page 281:
Standard primipara A woman with no
show all

National Women's Annual Clinical Report 2010

Create successful ePaper yourself

Delete template?

Save as template?